Document Detail


The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.
MedLine Citation:
PMID:  8637535     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Athletes often take androgenic steroids in an attempt to increase their strength. The efficacy of these substances for this purpose is unsubstantiated, however. METHODS: We randomly assigned 43 normal men to one of four groups: placebo with no exercise; testosterone with no exercise; placebo plus exercise; and testosterone plus exercise. The men received injections of 600 mg of testosterone enanthate or placebo weekly for 10 weeks. The men in the exercise groups performed standardized weight-lifting exercises three times weekly. Before and after the treatment period, fat-free mass was determined by underwater weighing, muscle size was measured by magnetic resonance imaging, and the strength of the arms and legs was assessed by bench-press and squatting exercises, respectively. RESULTS: Among the men in the no-exercise groups, those given testosterone had greater increases than those given placebo in muscle size in their arms (mean [+/-SE] change in triceps area, 424 +/- 104 vs. -81 +/- 109 square millimeters; P < 0.05) and legs (change in quadriceps area, 607 +/- 123 vs. -131 +/- 111 square millimeters; P < 0.05) and greater increases in strength in the bench-press (9 +/- 4 vs. -1 +/- 1 kg, P < 0.05) and squatting exercises (16 +/- 4 vs. 3 +/- 1 kg, P < 0.05). The men assigned to testosterone and exercise had greater increases in fat-free mass (6.1 +/- 0.6 kg) and muscle size (triceps area, 501 +/- 104 square millimeters; quadriceps area, 1174 +/- 91 square millimeters) than those assigned to either no-exercise group, and greater increases in muscle strength (bench-press strength, 22 +/- 2 kg; squatting-exercise capacity, 38 +/- 4 kg) than either no-exercise group. Neither mood nor behavior was altered in any group. CONCLUSIONS: Supraphysiologic doses of testosterone, especially when combined with strength training, increase fat-free mass and muscle size and strength in normal men.
Authors:
S Bhasin; T W Storer; N Berman; C Callegari; B Clevenger; J Phillips; T J Bunnell; R Tricker; A Shirazi; R Casaburi
Related Documents :
20437055 - The effect of aerobic versus strength-based training on high-sensitivity c-reactive pro...
16440505 - Myosin heavy chain isoform expression: influence on isoinertial and isometric performance.
15827935 - Use of step activity monitoring for continuous physical activity assessment in boys wit...
10879445 - Plasma catecholamine responses and neural adaptation during short-term resistance train...
9926165 - Comparison of the effects of salmeterol and ipratropium bromide on exercise performance...
19337275 - Blood lactate is an important energy source for the human brain.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The New England journal of medicine     Volume:  335     ISSN:  0028-4793     ISO Abbreviation:  N. Engl. J. Med.     Publication Date:  1996 Jul 
Date Detail:
Created Date:  1996-07-11     Completed Date:  1996-07-11     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0255562     Medline TA:  N Engl J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1-7     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Affect / drug effects
Anger / drug effects
Behavior / drug effects
Biomechanics
Body Weight / drug effects
Double-Blind Method
Gonadotropins, Pituitary / blood
Humans
Injections, Intramuscular
Lipids / blood
Male
Muscle, Skeletal / drug effects*,  physiology
Sex Hormone-Binding Globulin / analysis
Testosterone / administration & dosage*,  blood
Weight Lifting / physiology*
Grant Support
ID/Acronym/Agency:
1 RO1 DK 45211/DK/NIDDK NIH HHS; MO-00543//PHS HHS; P20RR11145-01/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Gonadotropins, Pituitary; 0/Lipids; 0/Sex Hormone-Binding Globulin; 58-22-0/Testosterone
Comments/Corrections
Comment In:
N Engl J Med. 1996 Jul 4;335(1):52-3   [PMID:  8637543 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Persons found in their homes helpless or dead.
Next Document:  Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granuloma...